Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
CYTOF
)
0.0825
UNCHANGED
Streaming Delayed Price
Updated: 12:34 PM EDT, Oct 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about CYTOF
Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results
August 29, 2025
Via
ACCESS Newswire
Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025
August 26, 2025
Via
ACCESS Newswire
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Intranasal Betahistine
July 15, 2025
Via
ACCESS Newswire
Altamira Therapeutics Announces Collaboration on Circular RNA Delivery
May 27, 2025
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Provides Business Update, Reports Full Year 2024 Financial Results
April 30, 2025
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics to Host Full Year 2024 Financial Results and Business Update Call on April 30, 2025
April 25, 2025
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Announces Notice of Allowance from USPTO for Bentrio Nasal Spray Patent
March 07, 2025
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
January 22, 2025
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of Circular RNA
December 31, 2024
From
Altamira Therapeutics Ltd
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Starting at $3.75
/
week.
Subscribe Today